BioSpace News Archive

BioMidwest

Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor

Tandem Diabetes Care’s t:slim X2 ™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre ® 2 Plus Sensor.

January 8, 2024
·
10 min read
Genetown

Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference

Viridian Therapeutics, Inc. today announced that President and Chief Executive Officer, Steve Mahoney, will discuss the company’s progress at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.

January 8, 2024
·
12 min read
Business

Predicine Announces Collaboration with Janssen to Develop PredicineCARE™ as a Companion Diagnostic Assay in Localized Bladder Cancer

Predicine, Inc., a leading molecular insights company, announced a collaboration with Janssen Pharmaceutica NV, a Johnson & Johnson company.

January 8, 2024
·
2 min read
Genetown

Sanguine Biosciences Adds Advanced Health Data Integration Capabilities that Further Enhance Translational Medical Research

Sanguine Biosciences announced advanced capabilities in acquiring and integrating electronic health records with donor specimens, further advancing its commitment to empowering patients to participate in medical research.

January 8, 2024
·
3 min read
Business

Deepcell Announces Collaboration with NVIDIA to Accelerate Use of Generative Artificial Intelligence in Single Cell Research

Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced a research collaboration with NVIDIA to accelerate the development and adoption of advanced computer vision solutions in life sciences.

January 8, 2024
·
3 min read
BioMidwest

Paterna Biosciences Announces Renowned Reproductive Biology Scientist Dr. Kyle Orwig as Co-Founder

Paterna Biosciences is pleased to announce Dr. Kyle Orwig has joined the company as a co-founder.

January 8, 2024
·
3 min read
Drug Development

Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer

Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today provided an update on the clinical response data for the ongoing AFM24-102 phase 1/2a study in EGFRwt NSCLC.

January 8, 2024
·
5 min read
Business

Accolade Announces Results for Fiscal Third Quarter 2024

Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2023.

January 8, 2024
·
15 min read
Pharm Country

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

Nuvation Bio Inc. (NYSE: NUVB) announced today that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate NUV-1511, the first clinical candidate from the company’s novel drug-drug conjugate (DDC) platform.

January 8, 2024
·
4 min read
Business

Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors

Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, announced the appointment of Robert Mashal, M.D. to its Board of Directors.

January 8, 2024
·
2 min read